Prolactin: What This Test Actually Measures

What Prolactin Is and Where It Comes From

Prolactin is a single-chain polypeptide hormone produced primarily by lactotroph cells in the anterior pituitary gland. Its gene sits on chromosome 6, and the mature circulating form weighs approximately 23 kDa [1]. Unlike most anterior pituitary hormones that require a releasing factor to enter circulation, prolactin secretion is under tonic inhibitory control by dopamine traveling down the tuberoinfundibular pathway from the hypothalamus to pituitary portal vessels [2].

This means anything that interrupts dopamine signaling, whether a tumor compressing the pituitary stalk, a dopamine-blocking medication, or hypothalamic disease, will raise prolactin. The hormone circulates in several molecular forms: monomeric (little prolactin, the bioactive form), dimeric (big prolactin), and high-molecular-weight complexes bound to IgG (big-big prolactin, or macroprolactin). Macroprolactin is biologically inert but immunoreactive, which matters for interpreting lab results [3].

Prolactin secretion follows a circadian rhythm. Levels peak during sleep (typically 2:00 to 5:00 AM) and reach their nadir in mid-morning. This is why the Endocrine Society recommends fasting morning draws, ideally 1 to 2 hours after waking, to avoid physiological elevations from sleep, stress, or nipple stimulation [4].

Why Clinicians Order a Prolactin Test

The test serves as a frontline screen for pituitary dysfunction and secondary hypogonadism. A single elevated prolactin level can explain an entire constellation of symptoms that might otherwise seem unrelated.

In premenopausal women, hyperprolactinemia suppresses gonadotropin-releasing hormone (GnRH) pulsatility, leading to oligomenorrhea or amenorrhea, anovulatory infertility, and galactorrhea. The 2011 Endocrine Society Clinical Practice Guideline recommends measuring serum prolactin in all women presenting with infertility, menstrual disturbance, or galactorrhea [4]. In men, elevated prolactin suppresses the hypothalamic-pituitary-gonadal axis, causing low testosterone, erectile dysfunction, decreased libido, and occasionally gynecomastia. A 2019 retrospective analysis in the Journal of Clinical Endocrinology & Metabolism found that 11% of men evaluated for secondary hypogonadism had previously undiagnosed hyperprolactinemia [5].

Beyond reproductive symptoms, prolactin measurement is essential when pituitary imaging reveals a sellar mass. The degree of elevation helps distinguish a prolactin-secreting adenoma from a non-functioning adenoma causing "stalk effect" elevation (typically <100 ng/mL) [4].

Normal Prolactin Ranges and How to Interpret Them

Reference intervals depend on sex, pregnancy status, and the specific immunoassay platform. The Endocrine Society defines the upper limit of normal as approximately 25 ng/mL (500 mU/L) in women and 20 ng/mL (400 mU/L) in men, though individual laboratory cutoffs vary slightly [4].

The degree of elevation carries diagnostic weight. Mild elevations (25 to 100 ng/mL) can result from medications, stress, macroprolactinemia, hypothyroidism, or a microprolactinoma (<10 mm). Moderate elevations (100 to 200 ng/mL) suggest either a larger microprolactinoma or significant stalk compression. Levels exceeding 200 ng/mL are nearly pathognomonic for a macroprolactinoma, and values above 1 to 000 ng/mL indicate an invasive giant prolactinoma [6].

One critical interpretive pitfall: the "hook effect." In two-site immunometric assays, extremely high prolactin concentrations (often >10 to 000 ng/mL) can saturate both the capture and signal antibodies simultaneously, producing a falsely normal or mildly elevated result. The Endocrine Society recommends requesting serial dilutions (1:100) whenever imaging shows a large macroadenoma but the prolactin level appears discordantly low [4]. Missing this artifact can lead to unnecessary transsphenoidal surgery on what is actually a medically treatable prolactinoma.

What Causes Prolactin to Rise

High prolactin falls into three broad etiologic categories: physiological, pharmacological, and pathological.

Physiological causes include pregnancy (levels rise progressively to 150 to 209 ng/mL by term), lactation, nipple stimulation, sleep, exercise, and physical or emotional stress [1]. A mildly elevated result drawn after a stressful venipuncture or without adequate fasting warrants a repeat measurement before further workup.

Pharmacological causes account for most cases of hyperprolactinemia encountered in clinical practice. Typical and atypical antipsychotics top the list. Risperidone produces the highest prolactin elevations among atypical antipsychotics, with mean levels reaching 45 to 96 ng/mL in some series [7]. Other offenders include metoclopramide, domperidone, SSRIs (modest elevations), tricyclic antidepressants, verapamil, and high-dose estrogen. The 2011 Endocrine Society guideline states: "Drug-induced hyperprolactinemia is the most common cause of prolactin levels between 25 and 100 ng/mL" [4].

Pathological causes center on prolactinomas. These benign pituitary adenomas represent approximately 40% of all pituitary tumors and are the most common functioning pituitary neoplasm [8]. Other pathological causes include non-functioning pituitary adenomas (stalk effect), craniopharyngiomas, primary hypothyroidism (thyrotropin-releasing hormone stimulates lactotrophs), chronic renal failure (reduced prolactin clearance), and chest wall lesions that stimulate intercostal nerves mimicking suckling.

What Causes Prolactin to Be Low

Hypoprolactinemia receives far less clinical attention. True prolactin deficiency, defined as levels below 3 ng/mL on a reliable assay, can indicate pituitary infarction (Sheehan syndrome), extensive pituitary surgery, or hypophysitis [9]. Dopamine agonist therapy (cabergoline, bromocriptine) deliberately lowers prolactin and can overshoot, suppressing levels below normal.

Emerging research suggests that very low prolactin may carry metabolic and immunological consequences. A 2020 systematic review in Pituitary noted associations between hypoprolactinemia and increased insulin resistance, reduced immune surveillance, and impaired psychological well-being, though causality remains unestablished [10]. For patients on dopamine agonist therapy whose prolactin has dropped below detectable limits, some endocrinologists now titrate doses to maintain measurable (rather than suppressed) levels, though no formal guideline mandates this practice.

How to Lower Prolactin: Clinical Approaches

Treatment depends entirely on the cause. Drug-induced hyperprolactinemia may resolve by switching to a prolactin-sparing alternative (aripiprazole in psychiatry, for example, acts as a partial dopamine agonist and can normalize prolactin) [7].

For prolactinomas, dopamine agonists are first-line therapy regardless of tumor size. Cabergoline (typical starting dose 0.25 mg twice weekly) normalizes prolactin in approximately 85% of patients with microprolactinomas and 70% with macroprolactinomas [11]. It also shrinks tumor volume by 50% or more in the majority of cases. The Endocrine Society recommends cabergoline over bromocriptine for most patients because of superior efficacy, fewer gastrointestinal side effects, and more convenient dosing [4].

Bromocriptine (1.25 to 2.5 mg daily, titrated up) remains preferred during fertility attempts in some centers because of its longer safety record in early pregnancy, though cabergoline discontinuation at pregnancy confirmation also appears safe based on registry data [4].

Transsphenoidal surgery is reserved for patients who are intolerant of or resistant to dopamine agonists, or who have specific complications such as cerebrospinal fluid leak or apoplexy. Surgical cure rates reach 80 to 90% for microprolactinomas in expert hands but drop to approximately 50% for macroprolactinomas [12].

How to Raise Prolactin: When It Matters

Intentionally raising prolactin is rarely a therapeutic goal. The clinical scenarios where low prolactin demands intervention are limited to postpartum lactation failure from Sheehan syndrome and iatrogenic oversuppression on dopamine agonists.

For oversuppression, the solution is dose reduction. Decreasing cabergoline by 0.25 mg increments every 4 to 6 weeks while monitoring serum prolactin allows careful titration back into the normal range. Complete withdrawal is appropriate in selected patients: the Endocrine Society suggests attempting cabergoline withdrawal after at least 2 years of therapy if prolactin has normalized and tumor volume has decreased substantially on MRI [4].

For Sheehan syndrome or panhypopituitarism, prolactin deficiency is typically managed in the context of broader hormone replacement (cortisol, thyroid, estrogen/testosterone), with lactation support provided through non-pharmacologic methods or donor milk.

No FDA-approved medication exists specifically to raise prolactin levels. Metoclopramide and domperidone have been used off-label to augment lactation by raising prolactin, though their primary indication is gastroparesis. Domperidone 10 mg three times daily increased prolactin levels by a mean of 119% in a small randomized trial of women with insufficient milk supply [13].

The Prolactin-Testosterone Connection

Hyperprolactinemia is an underrecognized cause of low testosterone in men. Elevated prolactin suppresses GnRH pulse frequency, reducing LH and FSH secretion and consequently lowering testicular testosterone production. This creates a pattern of secondary (central) hypogonadism that will not respond to clomiphene or hCG monotherapy unless the underlying hyperprolactinemia is corrected first.

The American Urological Association recommends measuring prolactin in men with low testosterone, particularly when LH is inappropriately low or normal [14]. A 2017 analysis published in the Journal of Sexual Medicine found that normalizing prolactin with cabergoline restored eugonadal testosterone levels in 67% of hypogonadal men with prolactinomas without requiring testosterone replacement therapy [15].

For men already receiving TRT who have persistently suppressed gonadotropins (expected on exogenous testosterone), measuring prolactin is still relevant if they develop new galactorrhea, visual field deficits, or headaches suggestive of a growing pituitary mass.

Practical Testing Considerations

Getting an accurate prolactin result requires attention to pre-analytical variables. The Endocrine Society recommends: fasting state, mid-morning draw (at least 1 hour after waking), avoidance of nipple stimulation or breast examination beforehand, minimal stress during venipuncture, and noting all current medications on the requisition [4].

If the initial result is mildly elevated (25 to 60 ng/mL) without obvious cause, repeat the draw on a separate day before ordering MRI. Stress-related elevations are common. If macroprolactin is suspected (mildly elevated prolactin in an asymptomatic patient), request polyethylene glycol (PEG) precipitation. PEG removes the IgG-bound macroprolactin complex; if >60% of the total immunoreactive prolactin is removed by PEG, the elevation is likely clinically insignificant [3].

Assay platforms matter. Different immunoassays (Roche Elecsys, Abbott Architect, Siemens Immulite) use different antibodies and calibrators. Results from one platform may not be directly comparable to another. When trending prolactin over time, particularly during dopamine agonist therapy, use the same laboratory and assay whenever possible.

When to Image: MRI Timing and Thresholds

Not every elevated prolactin requires brain MRI. The Endocrine Society recommends pituitary MRI with gadolinium when prolactin is confirmed elevated after excluding drug causes and physiological explanations, particularly when levels exceed 100 ng/mL or when symptoms suggest mass effect (headache, visual field cuts) [4].

For levels between 25 and 100 ng/mL, clinical judgment guides imaging decisions. A 28-year-old woman with amenorrhea and prolactin of 65 ng/mL after two confirmatory draws warrants MRI. A 45-year-old man on risperidone with prolactin of 55 ng/mL likely has a drug-induced elevation and may not need immediate imaging if levels normalize after medication adjustment.

Microadenomas (<10 mm) rarely grow. A longitudinal study of 139 untreated microprolactinomas found that only 7% showed any size increase over 4 to 6 years of follow-up [16]. This natural history supports watchful waiting in asymptomatic patients with small tumors and mild elevations who prefer to avoid medication.

Prolactin in Special Populations

Pregnancy: Prolactin rises 10- to 20-fold during normal pregnancy due to estrogen-driven lactotroph hyperplasia. This makes serum prolactin measurement unreliable for monitoring known prolactinomas during pregnancy. Instead, the Endocrine Society recommends clinical monitoring (visual field assessment, headache evaluation) and reserving MRI (without gadolinium) for symptomatic cases [4].

Chronic kidney disease: Reduced renal clearance raises prolactin in up to 30% of patients on dialysis. This elevation is typically modest (30 to 50 ng/mL) and may contribute to sexual dysfunction in this population [1].

Children and adolescents: Prolactin levels are higher in neonates and decline during childhood. Puberty-related elevations occur in girls. Reference intervals differ from adults, and pediatric endocrine consultation is appropriate for interpretation in young patients.